From the Editor-in-Chief
The impact of gene sequencing on the discovery and development of cancer treatments could be profound.
by William G. Nelson, MD, PhD
Patients must blend information from their doctors with their own values and beliefs.
by Kevin McLaughlin
Shining a Spotlight on Metastatic Breast Cancer | Getting Away From It All | Genetic Testing Can Help Women With Triple-Negative Breast Cancer | Medicare to Cover Lung Cancer Screening | Caring for the Caregivers | Does Testicular Cancer Screening Save Lives? | Please #CurbIt
Your Cancer Guide
Allowing others to assist you during and after treatment is an essential skill and a wonderful gift.
by Hester Hill Schnipper
Caregiving With Confidence
Caring for a loved one with cancer can change your life–often for the good.
by Deborah J. Cornwall
Sophisticated tests can generate a wealth of information about a patient's cancer or disease risk. But they also raise serious questions.
by Alexandra Goho
After a stage III cancer diagnosis, event planner Kim Hall Jackson gave up the illusion of control and started using her talents to promote screening among African-Americans.
by Leigh Labrie
Cancer often requires making difficult decisions in the face of uncertainty.
by Sue Rochman
Yesterday & Today
Susan Butcher won Alaska's grueling Iditarod dog-sled race four times. Her 2005 leukemia diagnosis marked the beginning of her greatest challenge.
by Jocelyn Selim
Stereotactic radiation therapy–heavily marketed to consumers–is gaining momentum as a more convenient treatment. But it's not for every patient.
by Sharon Reynolds
A Cup of Tea? | Movement Meditation
Researcher and social worker Mary Ann Burg discusses the long-term challenges cancer survivors face and recent efforts to address these needs.
by Marci A. Landsmann
Staying on the job through treatments, getting organized to care for a loved one, and remaining financially solvent through cancer care
Breast cancer survivor and hairstylist provides beauty expertise to breast cancer patients.
by Cynthia Ryan
Catie Clinard, Denise Manley Fox, David Frangioni.
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Can discussion of health inequities lead to actionable change?
by Marci A. Landsmann
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
While melanoma is less common than skin cancers like basal cell carcinoma or squamous cell carcinoma, it is much more deadly.
Learning Medicare’s ABCDs
donate to the AACR